{"entity":{"type":"insider","cik":"0001389046","url":"/insider/0001389046","json_url":"/insider/0001389046.json","name":"POLEWACZYK JAMES F","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":28,"n_filings":8,"first":"2011-02-22","last":"2024-03-07","span_basis":"filed_date"},"name_variants":[{"name":"POLEWACZYK JAMES F","source":"filing","n_filings":8,"first_seen":"2011-02-22","last_seen":"2024-03-07"}],"transactions":[{"id":2975189,"accession":"0000874716-24-000065","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0000874716-24-000065","line_url":"/filing/0000874716-24-000065","is_derivative":false,"issuer_cik":"0000874716","issuer_name":"IDEXX LABORATORIES INC /DE","issuer_ticker":"IDXX","issuer_name_source":null,"issuer_url":"/issuer/0000874716","owner_cik":"0001389046","owner_name":"POLEWACZYK JAMES F","owner_display_name":"POLEWACZYK JAMES F","owner_url":"/insider/0001389046","role":"Officer (Executive Vice President)","role_mark":"O","role_mark_label":"Officer (Executive Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Vice President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8104.0,"shares_display":"8,104","price_per_share":558.4398020730504,"price_display":"558.44","price_state":"stated","total_value":4525596.156,"total_display":"4,525,596.16","total_whole":"4,525,596","shares_owned_after":14681.2345,"shares_owned_after_display":"14,681.23","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-06","filed_date":"2024-03-07","scope":"insider","n_lines":3},{"id":8100244,"accession":"0000874716-23-000145","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000874716-23-000145","line_url":"/filing/0000874716-23-000145","is_derivative":false,"issuer_cik":"0000874716","issuer_name":"IDEXX LABORATORIES INC /DE","issuer_ticker":"IDXX","issuer_name_source":null,"issuer_url":"/issuer/0000874716","owner_cik":"0001389046","owner_name":"POLEWACZYK JAMES F","owner_display_name":"POLEWACZYK JAMES F","owner_url":"/insider/0001389046","role":"Officer (Executive Vice President)","role_mark":"O","role_mark_label":"Officer (Executive Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Vice President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11636.0,"shares_display":"11,636","price_per_share":521.7858503609488,"price_display":"521.79","price_state":"stated","total_value":6071500.1548,"total_display":"6,071,500.15","total_whole":"6,071,500","shares_owned_after":10049.9875,"shares_owned_after_display":"10,049.99","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-07","filed_date":"2023-12-08","scope":"insider","n_lines":4},{"id":8420717,"accession":"0000874716-23-000113","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0000874716-23-000113","line_url":"/filing/0000874716-23-000113","is_derivative":false,"issuer_cik":"0000874716","issuer_name":"IDEXX LABORATORIES INC /DE","issuer_ticker":"IDXX","issuer_name_source":null,"issuer_url":"/issuer/0000874716","owner_cik":"0001389046","owner_name":"POLEWACZYK JAMES F","owner_display_name":"POLEWACZYK JAMES F","owner_url":"/insider/0001389046","role":"Officer (Executive Vice President)","role_mark":"O","role_mark_label":"Officer (Executive Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Vice President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22909.0,"shares_display":"22,909","price_per_share":510.5611846872408,"price_display":"510.56","price_state":"stated","total_value":11696446.18,"total_display":"11,696,446.18","total_whole":"11,696,446","shares_owned_after":12924.9875,"shares_owned_after_display":"12,924.99","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-29","filed_date":"2023-08-31","scope":"insider","n_lines":6},{"id":4797840,"accession":"0001567619-21-021392","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-21-021392","line_url":"/filing/0001567619-21-021392#line-1","is_derivative":false,"issuer_cik":"0000874716","issuer_name":"IDEXX LABORATORIES INC /DE","issuer_ticker":"IDXX","issuer_name_source":null,"issuer_url":"/issuer/0000874716","owner_cik":"0001389046","owner_name":"POLEWACZYK JAMES F","owner_display_name":"POLEWACZYK JAMES F","owner_url":"/insider/0001389046","role":"Officer (Executive Vice President)","role_mark":"O","role_mark_label":"Officer (Executive Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Vice President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4595.0,"shares_display":"4,595","price_per_share":633.0,"price_display":"633.00","price_state":"stated","total_value":2908635.0,"total_display":"2,908,635.00","total_whole":"2,908,635","shares_owned_after":14818.2845,"shares_owned_after_display":"14,818.28","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-29","filed_date":"2021-12-01","scope":"insider"},{"id":4562554,"accession":"0001567619-21-011452","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001567619-21-011452","line_url":"/filing/0001567619-21-011452","is_derivative":false,"issuer_cik":"0000874716","issuer_name":"IDEXX LABORATORIES INC /DE","issuer_ticker":"IDXX","issuer_name_source":null,"issuer_url":"/issuer/0000874716","owner_cik":"0001389046","owner_name":"POLEWACZYK JAMES F","owner_display_name":"POLEWACZYK JAMES F","owner_url":"/insider/0001389046","role":"Officer (Executive Vice President)","role_mark":"O","role_mark_label":"Officer (Executive Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Vice President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":561.90565181,"price_display":"561.91","price_state":"stated","total_value":5619056.5181,"total_display":"5,619,056.52","total_whole":"5,619,057","shares_owned_after":22341.0,"shares_owned_after_display":"22,341","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-28","filed_date":"2021-06-01","scope":"insider","n_lines":8},{"id":3272309,"accession":"0001567619-20-009603","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001567619-20-009603","line_url":"/filing/0001567619-20-009603","is_derivative":false,"issuer_cik":"0000874716","issuer_name":"IDEXX LABORATORIES INC /DE","issuer_ticker":"IDXX","issuer_name_source":null,"issuer_url":"/issuer/0000874716","owner_cik":"0001389046","owner_name":"POLEWACZYK JAMES F","owner_display_name":"POLEWACZYK JAMES F","owner_url":"/insider/0001389046","role":"Officer (Executive Vice President)","role_mark":"O","role_mark_label":"Officer (Executive Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Vice President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16264.0,"shares_display":"16,264","price_per_share":298.85116770782093,"price_display":"298.85","price_state":"stated","total_value":4860515.3916,"total_display":"4,860,515.39","total_whole":"4,860,515","shares_owned_after":17772.0,"shares_owned_after_display":"17,772","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-11","filed_date":"2020-05-12","scope":"insider","n_lines":3},{"id":3227310,"accession":"0001140361-12-039465","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001140361-12-039465","line_url":"/filing/0001140361-12-039465#line-5","is_derivative":false,"issuer_cik":"0000874716","issuer_name":"IDEXX LABORATORIES INC /DE","issuer_ticker":"IDXX","issuer_name_source":null,"issuer_url":"/issuer/0000874716","owner_cik":"0001389046","owner_name":"POLEWACZYK JAMES F","owner_display_name":"POLEWACZYK JAMES F","owner_url":"/insider/0001389046","role":"Officer (Corporate Vice President)","role_mark":"O","role_mark_label":"Officer (Corporate Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Corporate Vice President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5459.0,"shares_display":"5,459","price_per_share":95.0102,"price_display":"95.01","price_state":"stated","total_value":518660.6818,"total_display":"518,660.68","total_whole":"518,661","shares_owned_after":6001.0,"shares_owned_after_display":"6,001","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-08-31","filed_date":"2012-09-05","scope":"insider"},{"id":8983464,"accession":"0001140361-11-011228","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001140361-11-011228","line_url":"/filing/0001140361-11-011228","is_derivative":false,"issuer_cik":"0000874716","issuer_name":"IDEXX LABORATORIES INC /DE","issuer_ticker":"IDXX","issuer_name_source":null,"issuer_url":"/issuer/0000874716","owner_cik":"0001389046","owner_name":"POLEWACZYK JAMES F","owner_display_name":"POLEWACZYK JAMES F","owner_url":"/insider/0001389046","role":"Officer (Corporate Vice President)","role_mark":"O","role_mark_label":"Officer (Corporate Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Corporate Vice President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17236.0,"shares_display":"17,236","price_per_share":77.60249494082154,"price_display":"77.60","price_state":"stated","total_value":1337556.6028,"total_display":"1,337,556.60","total_whole":"1,337,557","shares_owned_after":9875.0,"shares_owned_after_display":"9,875","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-02-17","filed_date":"2011-02-22","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":28,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":28,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":28},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000874716","name":"IDEXX LABORATORIES INC /DE","url":"/issuer/0000874716","role":"Officer (Executive Vice President)","n_filings":8,"first_seen":"2011-02-22","last_seen":"2024-03-07"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001389046","retrieved_at":"2026-08-24T17:31:39+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}